Matches in Nanopublications for { ?s ?p "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP865694.RABtiem1x-uq0r09yT8wfpTEhq-qyO_voOtpwf-I-HAlk130_assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865694.RABtiem1x-uq0r09yT8wfpTEhq-qyO_voOtpwf-I-HAlk130_provenance.
- NP859910.RAQGlLoSCfWJBz2yUNjq4TtRr0ZcWNn5eDJzG3sYruVAA130_assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859910.RAQGlLoSCfWJBz2yUNjq4TtRr0ZcWNn5eDJzG3sYruVAA130_provenance.
- assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP868037.RA66WOLh7xv9T2UfVercMUjlWN89GmGQyzMuAA4wuOzKs130_assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868037.RA66WOLh7xv9T2UfVercMUjlWN89GmGQyzMuAA4wuOzKs130_provenance.
- NP666606.RAL1uHanejLeGfV5UdvpchUClOLfs09lzBqeRQImf7KcQ130_assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666606.RAL1uHanejLeGfV5UdvpchUClOLfs09lzBqeRQImf7KcQ130_provenance.
- NP300439.RACu9ASYROtgrIatfI8T4DNrZSTXfTtVyjzhtBz1hh_3U130_assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300439.RACu9ASYROtgrIatfI8T4DNrZSTXfTtVyjzhtBz1hh_3U130_provenance.
- NP299967.RA1Lyh3krcV4Y2dSxxecd-AAaSIZdcR85XLuCI7KXkaTQ130_assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299967.RA1Lyh3krcV4Y2dSxxecd-AAaSIZdcR85XLuCI7KXkaTQ130_provenance.
- NP490228.RA2KHs6Uk2TO8nmWzm-J8Z69Wg4-eBjcF5wHHOVSWudew130_assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490228.RA2KHs6Uk2TO8nmWzm-J8Z69Wg4-eBjcF5wHHOVSWudew130_provenance.
- NP490232.RA7_uYOS5gxelECqRDFnyzO4koh0Pm4tFim5IQL48FbbU130_assertion description "[To investigate the consequences of overexpression of P-cadherin in terms of pancreatic carcinogenesis and tumor progression, we used a P-cadherin-deficient PDAC cell line, Panc-1, to construct a cell line (Panc1-CDH3) that stably overexpressed P-cadherin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490232.RA7_uYOS5gxelECqRDFnyzO4koh0Pm4tFim5IQL48FbbU130_provenance.